CN111172222B - Method for producing hyaluronic acid by fermentation and application thereof - Google Patents
Method for producing hyaluronic acid by fermentation and application thereof Download PDFInfo
- Publication number
- CN111172222B CN111172222B CN201911379590.2A CN201911379590A CN111172222B CN 111172222 B CN111172222 B CN 111172222B CN 201911379590 A CN201911379590 A CN 201911379590A CN 111172222 B CN111172222 B CN 111172222B
- Authority
- CN
- China
- Prior art keywords
- fermentation
- hyaluronic acid
- hours
- medium
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 139
- 230000004151 fermentation Effects 0.000 title claims abstract description 139
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 97
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 97
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 97
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 47
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 38
- 239000008103 glucose Substances 0.000 claims abstract description 38
- 241000120569 Streptococcus equi subsp. zooepidemicus Species 0.000 claims abstract description 29
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 230000004913 activation Effects 0.000 claims abstract description 6
- 239000001963 growth medium Substances 0.000 claims description 37
- 239000002609 medium Substances 0.000 claims description 36
- 238000011218 seed culture Methods 0.000 claims description 29
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 19
- 239000001888 Peptone Substances 0.000 claims description 15
- 108010080698 Peptones Proteins 0.000 claims description 15
- 235000019319 peptone Nutrition 0.000 claims description 15
- 238000012258 culturing Methods 0.000 claims description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 14
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 14
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 14
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 14
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 13
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 10
- 229940073490 sodium glutamate Drugs 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- 230000001502 supplementing effect Effects 0.000 claims description 6
- 238000012869 ethanol precipitation Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000005273 aeration Methods 0.000 claims description 3
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 229940014041 hyaluronate Drugs 0.000 claims description 2
- 239000002054 inoculum Substances 0.000 claims description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims 2
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 241001052560 Thallis Species 0.000 abstract description 3
- 238000011109 contamination Methods 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 238000004659 sterilization and disinfection Methods 0.000 description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 description 11
- 229940010747 sodium hyaluronate Drugs 0.000 description 11
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229960003589 arginine hydrochloride Drugs 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- 230000003796 beauty Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a method for producing hyaluronic acid by fermentation and application thereof. The method comprises the following steps: and (3) after the streptococcus zooepidemicus is subjected to activation and propagation, fermenting, adding a carbon source for one time in the fermentation process to obtain a hyaluronic acid fermentation liquid, and purifying to obtain hyaluronic acid. According to the fermentation method provided by the invention, the primary carbon source is added in the fermentation process, so that the glucose concentration in the fermentation liquid can be maintained, the fermentation period is shortened, the risk of bacterial contamination caused by adding the carbon source for many times is avoided, the normal growth and metabolism of thalli are facilitated, the problem of unbalance between the metabolism of streptococcus zooepidemicus and the expression of products is solved, and the obtained hyaluronic acid has high yield and large molecular weight.
Description
Technical Field
The invention belongs to the technical field of fermentation, and particularly relates to a method for producing hyaluronic acid by fermentation, in particular to a method for producing high-molecular medical-grade hyaluronic acid by fermentation and application thereof.
Background
Hyaluronic acid (HA for short) is a macromolecular mucopolysaccharide, and is a chain high polymer formed by repeatedly and alternately connecting glucuronic acid and N-acetamido glucosamine through beta-1, 3 and beta-1, 4 glycosidic bonds. Based on high viscosity, lubricity, water retention, good biocompatibility and special physiological effects of hyaluronic acid, the hyaluronic acid has wide application in the fields of medicine, beauty, health care food and the like. HA for different applications HAs different requirements on molecular weight, HA with medium molecular weight (molecular weight range 1,000-1,800 kda) is mainly used in cosmetics, while HA with high molecular weight (molecular weight range 1,800-2,200 kda) can be used in ophthalmic adhesive surgery, for treating arthrosis, soft tissue repair and as a drug carrier, etc., and HAs high application value in preventing and reducing postoperative tissue adhesion in particular.
The hyaluronic acid production method includes animal organ extraction method and bacterial fermentation method. When the extraction method is adopted to extract HA from animal viscera, the raw materials are limited, the production cost is high, the commodity price is high, and the wide application of the HA in medicines and cosmetics is limited. Compared with animal tissue extraction, the bacterial fermentation method HAs the advantages that the production scale is not limited by animal raw materials, HA in fermentation liquor exists in a free form, separation and purification are easy, cost is low, large-scale industrial production is easy to form, the risk of animal-derived pathogenic virus pollution is avoided, and the like.
CN101935678A discloses a method for producing hyaluronic acid fermentation liquor, which adds microelement liquor in a culture medium, wherein the microelement liquor consists of calcium chloride, zinc chloride, manganese sulfate and copper sulfate, and uses water for injection to prepare a seed culture medium and a fermentation culture medium, so that the problems of reduced hyaluronic acid yield and quality caused by lack of nutrient substances or improper preparation among various nutrient substances in the process of producing hyaluronic acid by bacterial fermentation are solved, however, the yield of hyaluronic acid is 6-7g/L, and the yield is still lower.
CN109536550a discloses a method for preparing sodium hyaluronate, which improves the yield of sodium hyaluronate, controls the molecular weight of sodium hyaluronate and expands the application field of sodium hyaluronate through reasonable planning of fermentation process and optimized preparation of fermentation medium. The method adopts a batch feeding method to supplement carbon sources during fermentation, and respectively supplements the carbon sources for five times at different times, so that the yield of the obtained hyaluronic acid is higher, but the method has the defects that the carbon sources are supplemented for many times, the fermentation period is longer, the fermentation liquid is easily polluted by miscellaneous bacteria, the quality of the hyaluronic acid is influenced, and the molecular weight of the obtained hyaluronic acid is lower.
Accordingly, there is a need to provide a fermentation process for preparing hyaluronic acid with a higher yield and a higher molecular weight of hyaluronic acid to meet the market demand.
Disclosure of Invention
Aiming at the defects existing in the prior art, the invention aims to provide a method for producing hyaluronic acid by fermentation and application thereof. The method is simple to operate, can shorten the fermentation period, increases the yield of the hyaluronic acid, and has higher molecular weight. To achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a method for fermentatively producing hyaluronic acid, comprising the steps of: and (3) after the streptococcus zooepidemicus is subjected to activation and propagation, fermenting, adding a carbon source for one time in the fermentation process to obtain a hyaluronic acid fermentation liquid, and purifying to obtain hyaluronic acid.
In the fermentation process, the initial glucose concentration is too high, which can inhibit the growth of strains, so that the fermentation period is prolonged, and the too low glucose concentration can influence the yield of hyaluronic acid.
Preferably, the content of hyaluronic acid in the hyaluronic acid fermentation broth is 10-15.5g/L, and can be 10g/L, 10.2g/L, 10.5g/L, 11g/L, 11.5g/L, 12g/L, 13g/L, 14g/L, 14.5g/L, 15g/L, 15.5g/L or the like.
Preferably, the molecular weight of the hyaluronic acid is 2200-4500kDa, for example 2200kDa, 2500kDa, 2800kDa, 3000kDa, 3500kDa, 4000kDa or 4500kDa, etc.
The hyaluronic acid obtained by the invention has higher yield which can basically reach 10-15.5g/L, and the molecular weight of the product is higher, can be used as a medicine-level high-molecular-weight raw material, and can be further developed into orthopaedics injection, eye drops, ophthalmic operation viscoelastic agent, injection beauty filling product, operation anti-adhesion product, and has wider application range and higher added value.
As a preferable technical scheme of the invention, the carbon source is glucose.
Preferably, the mass of the carbon source added to each liter of fermentation broth is 10-20g, and for example, 10g, 11g, 12g, 13g, 14g, 15g, 16g, 17g, 18g, 19g or 20g, etc. can be used.
Preferably, the time for supplementing the carbon source is 4 to 18 hours after transferring the strain to the fermentation medium after the expansion culture, and may be, for example, 4 hours, 5 hours, 6 hours, 8 hours, 10 hours, 12 hours, 14 hours, 16 hours or 18 hours, preferably 16 hours.
Preferably, the method comprises the steps of, the fermentation medium used in the fermentation includes 50-100g/L (e.g., 50g/L, 55g/L, 60g/L, 65g/L, 70g/L, 75g/L, 80g/L, 85g/L, 90g/L, 95g/L, 100g/L, etc.), 5-10g/L (e.g., 5g/L, 5.5g/L, 6g/L, 6.5g/L, 7g/L, 7.5g/L, 8g/L, 8.5g/L, 9g/L, 9.5g/L, 10g/L, etc.), yeast powder 10-20g/L (e.g., 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, etc.), yeast powder 19g/L or 20g/L, etc.), peptone 0.5-2g/L (e.g., may be 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, or 2g/L, etc.), magnesium sulfate 0.5-2g/L (e.g., may be 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, or 2g/L, etc.), monopotassium phosphate 10-20g/L (e.g., may be 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, 19g/L, or 20g/L, etc.) sodium glutamate and 1-5g/L (e.g., may be 1g/L, 1.5g/L, 2g/L, etc.), 2.5g/L, 3g/L, 3.5g/L, 4g/L, 4.5g/L, 5g/L, etc.) arginine hydrochloride.
Preferably, the transfer amount of the strain transferred to the fermentation medium after the expansion culture is 3-5%, for example, 3%, 3.2%, 3.5%, 3.8%, 4%, 4.2%, 4.5%, 4.8% or 5%, etc.
Preferably, the stirring speed at the time of fermentation is 100-500rpm, and for example, 100rpm, 150rpm, 200rpm, 250rpm, 300rpm, 350rpm, 400rpm, 450rpm, 500rpm, or the like may be used.
Preferably, the fermentation temperature is 33-37 ℃, for example, 33 ℃, 33.5 ℃, 34 ℃, 34.5 ℃, 35 ℃, 35.5 ℃, 36 ℃, 36.5 ℃, 37 ℃ or the like can be used.
Preferably, the fermentation time is 20-24h, and may be, for example, 20h, 20.5h, 21h, 21.5h, 22h, 22.5h, 23h, 23.5h, 24h, or the like.
Preferably, the aeration rate in the fermentation is 1 to 3 vm, for example, 1 vm, 1.2 vm, 1.5 vm, 2 vm, 2.2 vm, 2.5 vm, 2.6 vm, 2.8 vm, 3 vm, or the like.
As a preferable technical scheme of the invention, the fermentation process further comprises the step of adjusting the pH of the fermentation liquor by using a pH regulator.
Preferably, the pH adjuster is sodium hydroxide.
Preferably, the pH of the fermentation broth is maintained between 7.0 and 8.0, and may be, for example, 7.0, 7.2, 7.4, 7.6, 7.8, 7.9, 8.0, etc.
As a preferable embodiment of the present invention, the temperature at the time of activation in the method may be 33℃to 37℃such as 33.5℃to 34℃to 34.5℃to 35℃to 35.5℃to 36℃to 36.5℃or 37℃; the time is 10-14h, and can be, for example, 10h, 10.5h, 11h, 11.5h, 12h, 12.5h, 13h or 13.5h, etc.
Preferably, the medium used in the activation is shake flask seed medium.
Preferably, the method comprises the steps of, the shake flask seed medium comprises 1-10g/L (e.g., 1g/L, 2g/L, 4g/L, 5g/L, 6g/L, 8g/L, 9g/L, or 10g/L, etc.) glucose, 5-10g/L (e.g., 5g/L, 5.5g/L, 6g/L, 6.5g/L, 7g/L, 7.5g/L, 8g/L, 8.5g/L, 9g/L, 9.5g/L, or 10g/L, etc.), yeast powder, 10-20g/L (e.g., 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, 19g/L, or 20g/L, etc.) peptone, 0.5-2g/L (e.g., 0.5g/L, 0.8g/L, 1.2g, 1.5g/L, 1.2g, 2g, 2.1g, 2g, 2.5g, 2g, 2.1g, 2g, etc.), potassium sulfate, etc.
As a preferable embodiment of the present invention, the temperature at the time of the expansion culture in the method is 33 to 37℃and may be, for example, 33℃33.5℃34℃34.5℃35℃35.5℃36℃36.5℃37℃or the like; the time is 8-12 hours, and can be 8 hours, 8.5 hours, 9 hours, 9.5 hours, 10 hours, 10.5 hours, 11 hours, 11.5 hours or 12 hours, for example.
Between the zooepidemicus seed culture and the fermentation culture stage, a seed tank expanding culture step is added, so that the strain is quickly adapted to the nutrition environment provided by the fermentation culture medium, enters the fermentation stage, can quickly utilize the nutrition in the fermentation culture for growth, and shortens the fermentation period.
Preferably, the culture medium used in the expansion culture is a seed tank seed culture medium.
Preferably, the method comprises the steps of, the seed tank seed medium comprises 1-10g/L (e.g., 1g/L, 2g/L, 4g/L, 5g/L, 6g/L, 8g/L, 9g/L, or 10g/L, etc.) glucose, 5-10g/L (e.g., 5g/L, 5.5g/L, 6g/L, 6.5g/L, 7g/L, 7.5g/L, 8g/L, 8.5g/L, 9g/L, 9.5g/L, or 10g/L, etc.), yeast powder, 10-20g/L (e.g., 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, etc.), yeast powder, and yeast powder 19g/L or 20g/L, etc.), 0.5-2g/L (e.g., 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, or 2g/L, etc.), and 10-20g/L (e.g., 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, 19g/L, or 20g/L, etc.) of monosodium glutamate.
Preferably, the method used for purifying the hyaluronic acid fermentation broth is an ethanol precipitation method.
The ethanol precipitation method is a common method for separating various polysaccharides, and can be used for effectively dehydrating and decoloring hyaluronic acid, so that the product quality of the hyaluronic acid is improved, in order to completely precipitate the hyaluronic acid, about 1% of NaCl or NaAc is often added to achieve proper ion concentration, and the addition amount of ethanol is generally 2 times of the volume of fermentation liquor.
As a preferred technical scheme of the invention, the method comprises the following steps:
(1) Inoculating streptococcus zooepidemicus into shake flask seed culture medium, culturing at 33-37deg.C for 10-14 hr, transferring to seed tank seed culture medium, and culturing at 33-37deg.C for 8-12 hr;
(2) Inoculating Streptococcus zooepidemicus in seed culture medium of seed tank into fermentation culture medium at 3-5% inoculum size, fermenting at 33-37deg.C under stirring at 100-500rpm, introducing air volume of 1-3vvm, and maintaining pH of fermentation liquid at 7.0-8.0;
(3) Transferring the strain to a fermentation medium, adding a carbon source for 4-16 hours, wherein the fermentation time is 20-24 hours, obtaining hyaluronic acid fermentation liquor after fermentation, and purifying by an ethanol precipitation method to obtain hyaluronic acid.
In a second aspect, the present invention provides the use of a process as described in the first aspect for the preparation of pharmaceutical grade hyaluronic acid and/or hyaluronate.
The numerical ranges recited herein include not only the above-listed point values, but also any point values between the above-listed numerical ranges that are not listed, and are limited in space and for the sake of brevity, the present invention is not intended to be exhaustive of the specific point values that the stated ranges include.
Compared with the prior art, the invention has the beneficial effects that:
(1) The method for producing the hyaluronic acid by fermentation can maintain the concentration of glucose in fermentation liquor, is beneficial to the normal growth and metabolism of thalli, shortens the fermentation period, avoids the risk of bacterial contamination caused by adding carbon sources for many times, and solves the problems of small hyaluronic acid yield and molecular weight caused by unbalance between the metabolism of streptococcus zooepidemicus and the expression of products;
(2) The hyaluronic acid prepared by the method has high yield, the hyaluronic acid content in the hyaluronic acid fermentation liquor can reach 15.5g/L, the molecular weight is large, the application value of the hyaluronic acid with high molecular weight is high, and meanwhile, the method is simple to operate, short in fermentation period and high in production efficiency, and is beneficial to industrial production.
Detailed Description
The technical scheme of the invention is further described by the following specific embodiments. It will be apparent to those skilled in the art that the examples are merely to aid in understanding the invention and are not to be construed as a specific limitation thereof.
In the following examples, the seed solid medium used was formulated as follows: glucose 10g/L, yeast powder 5g/L, peptone 10g/L, magnesium sulfate 1g/L, potassium dihydrogen phosphate 1g/L, and agar 20g; the sterilization temperature is 115 ℃ and the sterilization time is 20 minutes after the culture medium is prepared.
In the following examples, the shake flask seed medium was used with the following formulation: glucose 10g/L, yeast powder 5g/L, peptone 10g/L, magnesium sulfate 1g/L, and potassium dihydrogen phosphate 1g/L; the sterilization temperature is 115 ℃ and the sterilization time is 20 minutes after the culture medium is prepared.
In the following examples, the formulation of the seed tank seed medium used was: glucose 10g/L, yeast powder 5g/L, peptone 10g/L, magnesium sulfate 1g/L, potassium dihydrogen phosphate 1g/L, and sodium glutamate 20g/L; the sterilization temperature is 115 ℃ and the sterilization time is 20 minutes after the culture medium is prepared.
In the following examples, the fermentation medium used was formulated as follows: the concentration of glucose is 90g/L, the concentration of yeast powder is 10g/L, the concentration of peptone is 20g/L, the concentration of magnesium sulfate is 0.5g/L, the concentration of potassium dihydrogen phosphate is 2g/L, the concentration of sodium glutamate is 20g/L, and the concentration of arginine hydrochloride is 5g/L; the sterilization temperature is 121 ℃ and the sterilization time is 30min after the culture medium is prepared.
Example 1
The embodiment provides a method for producing hyaluronic acid by fermentation, which comprises the following steps:
1. streptococcus zooepidemicus is used as a fermentation strain, inoculated onto a seed solid culture medium and cultured for 16 hours at 33 ℃;
2. inoculating streptococcus zooepidemicus into a shake flask seed culture medium for culture, and performing shake culture at 33 ℃ for 12 hours to obtain a streptococcus zooepidemicus shake flask seed culture solution;
3. inoculating the streptococcus zooepidemicus shake flask seed culture solution into a seed tank culture medium for culture, adjusting the pH of the culture solution by using 30% sodium hydroxide at the culture temperature of 33 ℃ to maintain the pH at 7.5, and culturing for 12 hours to obtain the streptococcus zooepidemicus seed tank seed culture solution;
4. inoculating seed culture solution of streptococcus zooepidemicus seed tank into a 50L fermentation tank, wherein the fermentation tank contains 30L fermentation medium, the inoculation amount is 5%, and the stirring speed is 250rpm after inoculation; culturing for 4 hours at 33 ℃ and pH value of 7.5 and ventilation of 1vvm, supplementing 10g glucose to each liter of fermentation liquor, continuing culturing, regulating the pH value of the fermentation liquor by 30% sodium hydroxide in the fermentation process to keep the pH value at 7.5+/-0.5, and fermenting for 24 hours to obtain 30L of hyaluronic acid fermentation liquor;
5. 200g of NaCl is added into the obtained fermentation liquor, 58L of ethanol is added to separate out sodium hyaluronate to obtain sodium hyaluronate, the amount of hyaluronic acid is converted according to the yield of sodium hyaluronate, meanwhile, the intrinsic viscosity is measured by adopting a Ping Shi viscometer, the relative molecular weight is converted, the yield of the obtained hyaluronic acid is 10.2g/L, and the molecular weight of the hyaluronic acid is 2200kDa.
Example 2
The same as in example 1, except that 10g of glucose was fed per liter of fermentation broth at 8 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid was 10.6g/L, and the molecular weight of the hyaluronic acid was 2400kDa.
Example 3
The same as in example 1, except that 10g of glucose was fed per liter of fermentation broth at 12 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid was 10.7g/L, and the molecular weight of the hyaluronic acid was 3000kDa.
Example 4
The same as in example 1, except that 10g of glucose was fed per liter of fermentation broth at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid was 12.4g/L, and the molecular weight of the hyaluronic acid was 3600kDa.
Example 5
The same as in example 1, except that 10g of glucose was fed per liter of fermentation broth at 18 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid was 11.2g/L, and the molecular weight of the hyaluronic acid was 3400kDa.
Example 6
The same as in example 1, except that a 500L fermenter was used in this example, the volume of the fermentation medium was 300L, and 10g of glucose was fed per liter of fermentation broth 16 hours after switching to the fermentation medium; the yield of the obtained hyaluronic acid was 12.8g/L, and the molecular weight of the hyaluronic acid was 3800kDa.
Example 7
The same as in example 1, except that 5g of glucose per liter of fermentation broth was fed in 16 hours after switching to the fermentation medium; the yield of the obtained hyaluronic acid was 9.3g/L, and the molecular weight of the hyaluronic acid was 3200kDa.
Example 8
The same as in example 1, except that 8g of glucose was fed per liter of fermentation broth at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid was 10.6g/L, and the molecular weight of the hyaluronic acid was 3400kDa.
Example 9
The same as in example 1, except that 15g of glucose per liter of fermentation broth was fed in 16 hours after switching to the fermentation medium; the yield of the obtained hyaluronic acid was 14.2g/L, and the molecular weight of the hyaluronic acid was 4000kDa.
Example 10
The same as in example 1, except that 20g of glucose was fed per liter of fermentation broth at 16 hours after transfer to the fermentation medium; the yield of hyaluronic acid obtained was 15.5g/L, the molecular weight of which was 4200kDa.
Example 11
The same as in example 1, except that 25g of glucose per liter of fermentation broth was fed in 16 hours after switching to the fermentation medium; the yield of the obtained hyaluronic acid was 15.0g/L, and the molecular weight of the hyaluronic acid was 4200kDa.
Example 12
The same as in example 1, except that a 500L fermenter was used in this example, the volume of the fermentation medium was 300L, and 15g of glucose was fed per liter of fermentation broth 16 hours after switching to the fermentation medium; the yield of the obtained hyaluronic acid was 14.4g/L, and the molecular weight of the hyaluronic acid was 4500kDa.
Comparative example 1
The method for producing the hyaluronic acid fermentation liquor by taking streptococcus zooepidemicus as a fermentation strain comprises the following steps:
1. inoculating streptococcus zooepidemicus to seed solid culture for culturing, and culturing at 33 ℃ for 16 hours;
2. preparing a shake flask seed culture medium: glucose 10g/L, yeast powder 5g/L, peptone 10g/L, magnesium sulfate 1g/L, and potassium dihydrogen phosphate 1g/L; the sterilization temperature is 115 ℃ and the sterilization time is 20 minutes after the culture medium is prepared.
Inoculating streptococcus zooepidemicus into a seed culture medium for culture, and carrying out shaking culture at 33 ℃ for 12 hours to obtain streptococcus zooepidemicus seed culture solution.
3. Preparing a seed tank seed culture medium: glucose 10g/L, yeast powder 5g/L, peptone 10g/L, magnesium sulfate 1g/L, potassium dihydrogen phosphate 1g/L, sodium glutamate 20g/L, and sterilizing temperature 115 deg.C for 20 min.
Inoculating streptococcus zooepidemicus into a seed tank culture medium for culture, wherein the seed culture condition is that the temperature is 33 ℃, the pH is regulated to 6.0-8.0 by 30% sodium hydroxide, and the culture is carried out for 8-12 hours to obtain the streptococcus zooepidemicus seed culture solution.
4. Preparing a fermentation tank culture medium
The concentration of glucose is 100g/L, the concentration of yeast powder is 10g/L, the concentration of peptone is 20g/L, the concentration of magnesium sulfate is 0.5g/L, the concentration of potassium dihydrogen phosphate is 2g/L, and the concentration of sodium glutamate is 20g/L; arginine hydrochloride 5g/L, sterilizing temperature 121 deg.C, sterilizing time 30min.
Inoculating streptococcus zooepidemicus seed culture solution to fermentation culture solution, regulating the pH value of the fermentation solution by 30% sodium hydroxide in the fermentation process under the conditions of stirring rotation speed of 200rpm, temperature of 33 ℃, pH value of 7.5 and ventilation of 1vvm, so that the pH value is kept at 7.5+/-0.5, and culturing for 24 hours to obtain hyaluronic acid fermentation solution;
5. 200g of NaCl was added to the obtained fermentation broth, and 58L of ethanol was added to precipitate sodium hyaluronate to obtain sodium hyaluronate, whereby the yield of the obtained hyaluronic acid was 8.1g/L, and the molecular weight of the hyaluronic acid was 1800kDa.
Comparative example 2
1. Inoculating streptococcus zooepidemicus to seed solid culture for culturing, and culturing at 33 ℃ for 16 hours;
2. preparing a shake flask seed culture medium: glucose 10g/L, yeast powder 5g/L, peptone 10g/L, magnesium sulfate 1g/L, and potassium dihydrogen phosphate 1g/L; the sterilization temperature is 115 ℃ and the sterilization time is 20 minutes after the culture medium is prepared.
Inoculating streptococcus zooepidemicus into a seed culture medium for culture, and carrying out shaking culture at 33 ℃ for 12 hours to obtain streptococcus zooepidemicus seed culture solution.
3. Preparing a seed tank seed culture medium: glucose 10g/L, yeast powder 5g/L, peptone 10g/L, magnesium sulfate 1g/L, potassium dihydrogen phosphate 1g/L, sodium glutamate 20g/L, and sterilizing temperature 115 deg.C for 20 min.
Inoculating streptococcus zooepidemicus into a seed tank culture medium for culture, wherein the seed culture condition is that the temperature is 33 ℃, the pH is regulated to 8.0 by 30% sodium hydroxide, and the culture is carried out for 8-12 hours to obtain the streptococcus zooepidemicus seed culture solution.
4. Preparing a fermentation tank culture medium
The concentration of glucose is 90g/L, the concentration of yeast powder is 10g/L, the concentration of peptone is 20g/L, the concentration of magnesium sulfate is 0.5g/L, the concentration of potassium dihydrogen phosphate is 2g/L, and the concentration of sodium glutamate is 20g/L; arginine hydrochloride 5g/L, sterilizing temperature 121 deg.C, sterilizing time 30min.
Inoculating streptococcus zooepidemicus seed culture solution to fermentation culture solution, culturing for 4 hours under the conditions that the stirring rotation speed is 200rpm, the temperature is 33 ℃, the pH value is 7.5 and the ventilation rate is 1vvm, supplementing 2g glucose per liter of fermentation solution in 8 hours and supplementing 6g glucose per liter of fermentation solution in 16 hours; regulating the pH value of the fermentation liquor by 30% sodium hydroxide in the fermentation process to ensure that the pH value is maintained at 7.5+/-0.5, and culturing for 24 hours to obtain hyaluronic acid fermentation liquor;
5. 286g NaCl was added to the obtained fermentation broth, and 72L ethanol was further added to precipitate sodium hyaluronate to obtain sodium hyaluronate, whereby the yield of the obtained hyaluronic acid was found to be 12.1g/L, and the molecular weight of the hyaluronic acid was found to be 3500kDa.
The glucose addition times, addition amounts, and resultant hyaluronic acid yields and hyaluronic acid molecular weights in examples 1 to 12 and comparative examples 1 to 2 above are shown in table 1.
TABLE 1
From the data in Table 1, it is clear from comparison between example 4 and comparative examples 1 to 2 that the hyaluronic acid obtained in example 4 has a higher yield and a higher molecular weight, compared with the case of directly increasing the carbon source content in the fermentation medium without adding the carbon source in comparative example 1, in which the carbon source is added in an equal amount for a plurality of times in comparative example 2; as can be seen from comparison of example 4 and example 6 and comparison of example 9 and example 12, the 500L tank and the 50L tank are different in stirring form, the 500L tank is more fully stirred, the aeration and dissolved oxygen state is better, the bacterial growth is facilitated, and the yield and molecular weight of hyaluronic acid can be improved; however, when the added amount of glucose is further increased during the amplification experiment, the yields of hyaluronic acid obtained from the 500L tank and the 50L tank are more and more similar to the molecular weight; as is clear from a comparison of example 4 and example 5, the optimum time point for adding the carbon source was 16 hours, 18 hours, and the yield was reduced, and the molecular weight was no longer increased; as is clear from comparison of examples 4 and examples 7 to 11, the yield of hyaluronic acid increases with the amount of carbon source supplementation, and the higher the supplementation amount, the higher the yield of hyaluronic acid and the higher the molecular weight, but when the carbon source supplementation amount exceeds 20g/L, for example, the addition amount in example 11 is 25g/L, the yield of hyaluronic acid is not increased any more, indicating that the yield of hyaluronic acid is limited when the carbon source concentration exceeds a certain range.
In summary, the fermentation method provided by the invention can maintain the glucose concentration in the fermentation liquid, shortens the fermentation period, avoids the risk of bacterial contamination caused by adding carbon sources for many times, is beneficial to normal growth and metabolism of thalli, and solves the problem of unbalance between metabolism of streptococcus zooepidemicus and expression of products, and the obtained hyaluronic acid has high yield and large molecular weight.
The applicant declares that the above is only a specific embodiment of the present invention, but the scope of the present invention is not limited thereto, and it should be apparent to those skilled in the art that any changes or substitutions that are easily conceivable within the technical scope of the present invention disclosed by the present invention fall within the scope of the present invention and the disclosure.
Claims (19)
1. A method for producing hyaluronic acid by fermentation, comprising the steps of:
activating and expanding culture streptococcus zooepidemicus, fermenting, adding a carbon source for one time in the fermentation process to obtain hyaluronic acid fermentation liquor, and purifying to obtain hyaluronic acid;
the fermentation culture medium used in the fermentation comprises 90-100g/L glucose, 5-10g/L yeast powder, 10-20g/L peptone, 0.5-2g/L magnesium sulfate, 0.5-2g/L potassium dihydrogen phosphate, 10-20g/L sodium glutamate and 1-5g/L arginine hydrochloride;
the carbon source is glucose;
the mass of the carbon source added into each liter of fermentation liquor is 10-20g;
the time for supplementing the carbon source is 12-18 hours after transferring the strain to the fermentation culture medium after the expansion culture;
the content of hyaluronic acid in the hyaluronic acid fermentation liquor is 10-15.5g/L;
the molecular weight of the hyaluronic acid is 2200-4500kDa.
2. The method of claim 1, wherein the time for supplementing the carbon source is 16 hours after transferring the strain to the fermentation medium after the expanding culture.
3. The method of claim 1, wherein the transfer of the strain to the fermentation medium after the propagation is 3-5%.
4. The method according to claim 1, wherein the stirring speed during fermentation is 100-500rpm.
5. The method of claim 1, wherein the fermentation temperature is 33-37 ℃.
6. The method of claim 1, wherein the fermentation time is 20-24 hours.
7. The method of claim 1, wherein the aeration during fermentation is 1-3vvm.
8. The method of claim 1, further comprising the step of adjusting the pH of the fermentation broth using a pH adjuster.
9. The method of claim 8, wherein the pH adjuster is sodium hydroxide.
10. The method of claim 8, wherein the pH of the fermentation broth is maintained between 7.0 and 8.0.
11. The method according to claim 1, wherein the temperature at which the activation is performed is 33-37 ℃ for a period of 10-14 hours.
12. The method of claim 1, wherein the medium used in the activation is shake flask seed medium.
13. The method of claim 12, wherein the shake flask seed medium comprises 1-10g/L glucose, 5-10g/L yeast powder, 10-20g/L peptone, 0.5-2g/L magnesium sulfate, and 0.5-2g/L potassium dihydrogen phosphate.
14. The method according to claim 1, wherein the temperature during the propagation is 33-37 ℃ and the time is 8-12 hours.
15. The method of claim 1, wherein the culture medium used in the expanding culture is a seed tank seed culture medium.
16. The method of claim 15, wherein the seed tank seed medium comprises 1-10g/L glucose, 5-10g/L yeast powder, 10-20g/L peptone, 0.5-2g/L magnesium sulfate, 0.5-2g/L potassium dihydrogen phosphate, and 10-20g/L sodium glutamate.
17. The method of claim 1, wherein the method used to purify the hyaluronic acid fermentation broth is an ethanol precipitation method.
18. The method according to claim 1, characterized in that it comprises the steps of:
(1) Inoculating streptococcus zooepidemicus into shake flask seed culture medium, culturing at 33-37deg.C for 10-14 hr, transferring to seed tank seed culture medium, and culturing at 33-37deg.C for 8-12 hr;
(2) Inoculating Streptococcus zooepidemicus in seed culture medium of seed tank into fermentation culture medium at 3-5% inoculum size, fermenting at 33-37deg.C under stirring at 100-500rpm, introducing air volume of 1-3vvm, and maintaining pH of fermentation liquid at 7.0-8.0;
(3) Transferring the strain to a fermentation medium, adding a carbon source for 12-18 hours, wherein the fermentation time is 20-24 hours, obtaining hyaluronic acid fermentation liquor after fermentation, and purifying by an ethanol precipitation method to obtain hyaluronic acid.
19. Use of a process according to any one of claims 1-18 for the preparation of pharmaceutical grade hyaluronic acid and/or hyaluronate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911379590.2A CN111172222B (en) | 2019-12-27 | 2019-12-27 | Method for producing hyaluronic acid by fermentation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911379590.2A CN111172222B (en) | 2019-12-27 | 2019-12-27 | Method for producing hyaluronic acid by fermentation and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111172222A CN111172222A (en) | 2020-05-19 |
CN111172222B true CN111172222B (en) | 2024-03-26 |
Family
ID=70624672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911379590.2A Active CN111172222B (en) | 2019-12-27 | 2019-12-27 | Method for producing hyaluronic acid by fermentation and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111172222B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110452944A (en) * | 2019-09-21 | 2019-11-15 | 冯世红 | A method of hyaluronic acid is prepared using salt alcohol method |
CN114806938B (en) * | 2022-04-20 | 2023-05-09 | 齐鲁工业大学 | Streptococcus equi subspecies zooepidemicus for producing hyaluronic acid in low-sugar environment and application thereof |
CN115960979A (en) * | 2022-12-30 | 2023-04-14 | 华熙生物科技股份有限公司 | Method for producing hyaluronic acid or salt thereof by fermentation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103320484A (en) * | 2013-06-28 | 2013-09-25 | 四川柯森油田化学有限公司 | Method for improving the fermentation yield of hyaluronic acid (HA) |
CN108192936A (en) * | 2018-03-19 | 2018-06-22 | 山东焦点生物科技股份有限公司 | A kind of feed process of hyaluronic acid fermentation |
CN109468355A (en) * | 2018-10-16 | 2019-03-15 | 河北科技大学 | A method of improving fermenting and producing hyaluronan molecule amount |
CN109536550A (en) * | 2018-12-06 | 2019-03-29 | 上海景峰制药有限公司 | A kind of Sodium Hyaluronate and preparation method thereof |
-
2019
- 2019-12-27 CN CN201911379590.2A patent/CN111172222B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103320484A (en) * | 2013-06-28 | 2013-09-25 | 四川柯森油田化学有限公司 | Method for improving the fermentation yield of hyaluronic acid (HA) |
CN108192936A (en) * | 2018-03-19 | 2018-06-22 | 山东焦点生物科技股份有限公司 | A kind of feed process of hyaluronic acid fermentation |
CN109468355A (en) * | 2018-10-16 | 2019-03-15 | 河北科技大学 | A method of improving fermenting and producing hyaluronan molecule amount |
CN109536550A (en) * | 2018-12-06 | 2019-03-29 | 上海景峰制药有限公司 | A kind of Sodium Hyaluronate and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
吴祥坤等.葡萄糖浓度及补料方式对透明质酸发酵的影响.《食品工业科技》.2016,第第37卷卷(第第37卷期),第199页第1.2.2、1.3.2节. * |
张容鹄等.高分子量透明质酸产生菌选育及发酵条件优化.《中国酿造》.2008,第17-21页. * |
郜娇娇等.微生物发酵法生产高分子量透明质酸的研究进展.《中国生物工程杂志》.2017,第第37卷卷(第第37卷期),第118-125页. * |
Also Published As
Publication number | Publication date |
---|---|
CN111172222A (en) | 2020-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111172222B (en) | Method for producing hyaluronic acid by fermentation and application thereof | |
Freitas et al. | Engineering aspects of microbial exopolysaccharide production | |
CN106119322B (en) | A kind of zymotechnique improving recombination human source collagen production level | |
Ai et al. | Improved welan gum production by Alcaligenes sp. ATCC31555 from pretreated cane molasses | |
CN101935678B (en) | Method for producing hyaluronic acid fermentation liquor | |
Liu et al. | Efficient production of high-molecular-weight hyaluronic acid with a two-stage fermentation | |
Antunes et al. | Conversion of cheese whey into a fucose-and glucuronic acid-rich extracellular polysaccharide by Enterobacter A47 | |
CN104805143B (en) | A kind of method for preparing low molecule amount γ polyglutamic acids | |
CN109468355A (en) | A method of improving fermenting and producing hyaluronan molecule amount | |
CN106834387A (en) | A kind of method for preparing sodium hyaluronate | |
CN106367459A (en) | Method for preparing oligomeric hyaluronic acid with different molecular weights | |
CN102533889A (en) | Method for continuously fermenting lysine | |
CN110577977A (en) | Method for producing glucosamine by fermenting escherichia coli | |
US6605461B2 (en) | Production of exopolysaccharides unattached to the surface of bacterial cells | |
Aroskar et al. | Effect of various nutritional supplements on hyaluronic acid production | |
CN112680435A (en) | Preparation method of sphingosine gum lyase and enzymatic sphingosine gum | |
Lai et al. | Medium formulation and impeller design on the biosynthesis of high molecular weight hyaluronic acid by Streptococcus zooepidemicus ATCC 39920 | |
CN111996136A (en) | Pseudomonas fluorescens fermentation medium, culture method and application | |
Moraes et al. | The existing studies on biosynthesis of poly (γ-glutamic acid) by fermentation. | |
Saharkhiz et al. | Optimization Feed Composition on Hyaluronic Acid Production of in-Batch and Fed-Batch Cultures of Streptococcus zooepidemicus | |
CN113652456A (en) | Method for producing pullulan polysaccharide by cell recycling and application | |
CN105349590B (en) | Method for producing glutamine by microbial fermentation feeding | |
CN112553277B (en) | Method for improving fermentation level of polymyxin B sulfate | |
CN104404113B (en) | A kind of supplemented medium of vancomycin and the method for producing vancomycin | |
CN1891834A (en) | Fermenting method for producing natamycin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |